Does consuming isoflavones reduce or increase breast cancer risk?

Genome Medicine

Volumn 2, Issue 12, 2010, Pages

  Bondesson, Maria ^a,b   Gustafsson, Jan Ake ^a,b  

^a University of Houston   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN; GENISTEIN; GLYCITEIN; ISOFLAVONE;

BONE DENSITY; BREAST CANCER; BREAST CELL; CANCER RISK; CARDIOVASCULAR DISEASE; ESTROGEN BLOOD LEVEL; FEMALE; FEMUR NECK; HIP; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; MOLECULAR MECHANICS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINE; STEM CELL; TUMOR MODEL;

EID: 78751679919     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm211     Document Type: Review

References (31)

1. Bolanos R, Del Castillo A, Francia J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause 2010, 17:660-666. 10.1097/gme.0b013e3181df48f0, 20464785.
2. Taku K, Melby MK, Takebayashi J, Mizuno S, Ishimi Y, Omori T, Watanabe S. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 2010, 19:33-42.
3. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044. 10.1161/CIRCULATIONAHA.106.171052, 16418439.
4. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006, 98:459-471. 10.1093/jnci/djj102, 16595782.
5. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2010, 125:315-323. 10.1007/s10549-010-1270-8, 21113655.
6. Hooper L, Madhavan G, Tice JA, Leinster SJ, Cassidy A. Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update 2010, 16:745-760. 10.1093/humupd/dmq011, 2953939, 20511398.
7. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 2008, 98:1485-1493. 10.1038/sj.bjc.6604321, 2391102, 18392054.
8. Martínez-Montemayor MM, Otero-Franqui E, Martinez J, De La Mota-Peynado A, Cubano LA, Dharmawardhane S. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clin Exp Metastasis 2010, 27:465-480. 2944964, 20517637.
9. Kim HA, Jeong KS, Kim YK. Soy extract is more potent than genistein on tumor growth inhibition. Anticancer Res 2008, 28:2837-2842.
10. Byun JS, Han YS, Lee SS. The effects of yellow soybean, black soybean, and sword bean on lipid levels and oxidative stress in ovariectomized rats. Int J Vitam Nutr Res 2010, 80:97-106. 10.1024/0300-9831/a000010, 20803424.
11. Salvo VA, Boue SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM, Curiel TJ, Srivastav SK, Shih BY, Carter-Wientjes C, Wood CE, Erhardt PW, Beckman BS, McLachlan JA, Cleveland TE, Burow ME. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 2006, 12:7159-7164. 10.1158/1078-0432.CCR-06-1426, 17145841.
12. Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, Nurmi T, van der Saag PT, Makela SI. Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 2009, 53:996-1006. 10.1002/mnfr.200800487, 19603405.
13. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 2009, 15:423-440. 10.1093/humupd/dmp010, 2691652, 19299447.
14. Sotoca AM, Sollewijn Gelpke MD, Boeren S, Ström A, Gustafsson JA, Murk AJ, Rietjens IM, Vervoort J. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics 2010,
15. Satih S, Chalabi N, Rabiau N, Bosviel R, Fontana L, Bignon YJ, Bernard-Gallon DJ. Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach. OMICS 2010, 14:231-238. 10.1089/omi.2009.0124, 20455703.
16. Jawaid K, Crane SR, Nowers JL, Lacey M, Whitehead SA. Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors. J Steroid Biochem Mol Biol 2010, 120:164-171. 10.1016/j.jsbmb.2010.04.007, 20399854.
17. Li Y, Liu L, Andrews LG, Tollefsbol TO. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 2009, 125:286-296. 10.1002/ijc.24398, 2995334, 19358274.
18. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006, 66:5624-5632. 10.1158/0008-5472.CAN-06-0516, 2276876, 16740699.
19. Simões BM, Piva M, Iriondo O, Comaills V, López-Ruiz JA, Zabalza I, Mieza JA, Acinas O, Vivanco MD. Effects of estrogen on the proportion of stem cells in the breast. Breast Cancer Res Treat 2010,
20. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W. Soy food intake and breast cancer survival. JAMA 2009, 302:2437-2443. 10.1001/jama.2009.1783, 2874068, 19996398.
21. Guha N, Kwan ML, Quesenberry CP, Weltzien EK, Castillo AL, Caan BJ. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 2009, 118:395-405. 10.1007/s10549-009-0321-5, 19221874.
22. Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 2007, 58:249-258.
23. Palacios S, Pornel B, Vázquez F, Aubert L, Chantre P, Marès P. Long-term endometrial and breast safety of a specific, standardized soy extract. Climacteric 2010, 13:368-375. 10.3109/13697131003660585, 20380569.
24. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987, 262:5592-5595.
25. Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In Vitro 2008, 22:1749-1753. 10.1016/j.tiv.2008.08.001, 18761399.
26. Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol Toxicol 2008, 24:401-409. 10.1007/s10565-008-9054-1, 18224451.
27. Anastasius N, Boston S, Lacey M, Storing N, Whitehead SA. Evidence that low-dose, long-term genistein treatment inhibits oestradiol-stimulated growth in MCF-7 cells by down-regulation of the PI3-kinase/Akt signalling pathway. J Steroid Biochem Mol Biol 2009, 116:50-55. 10.1016/j.jsbmb.2009.04.009, 19406242.
28. Sakla MS, Shenouda NS, Ansell PJ, Macdonald RS, Lubahn DB. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocrine 2007, 32:69-78. 10.1007/s12020-007-9006-1, 17992604.
29. Privat M, Aubel C, Arnould S, Communal Y, Ferrara M, Bignon YJ. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines. Anticancer Res 2010, 30:2049-2054.
30. Chen WF, Gao QG, Wong MS. Mechanism involved in genistein activation of insulin-like growth factor 1 receptor expression in human breast cancer cells. Br J Nutr 2007, 98:1120-1125. 10.1017/S0007114507777139, 17617943.
31. Reiter E, Beck V, Medjakovic S, Mueller M, Jungbauer A. Comparison of hormonal activity of isoflavone-containing supplements used to treat menopausal complaints. Menopause 2009, 16:1049-1060. 10.1097/gme.0b013e31819c146c, 19430319.